Skip Navigation

ALS Clinic at Johns Hopkins

flower up close

The ALS Clinic at Johns Hopkins


The Johns Hopkins ALS Clinic is a world recognized leader in providing superior medical care and offering the latest in clinical trials and therapies to ALS patients. Located with the Johns Hopkins Hospital in East Baltimore, the Clinic provides comprehensive care and disease education from initial diagnosis to advanced disease. Their compassionate team provides support for patients and their families with a  therapeutic goal to maximize a patient's health, functioning, and ability using available therapy, equipment, exercise, and nutrition. Clinical research participation is offered to all appropriate and eligible ALS clinic patients. 

Once diagnosis is confirmed by a neurologist, the ALS clinical team directed by Lora L. Clawson, MSN, CRNP creates a clinical care plan after a thorough assessment by all team members. 

This world-respected medical destination for amyotrophic lateral sclerosis (ALS) patients is not a part of the Packard Center, although Clinic patients often sign up for studies, or clinical trials, that test potential Center-derived therapies.  The Packard Center does not diagnose or provide clinical care to patients. It does, does work cosely with the Clinic to help promote their work, support clinical trials as well as basic research.

For more information or to schedule an appointment, please visit the Johns Hopkins ALS Clinic web site.

Gabsang Lee

Our Experts

Johns Hopkins University
Gabsang Lee has spent his career studying diseases of the peripheral nervous system- those neurons outside of the brain and spinal cord. But his pioneering work in transforming fibroblasts obtained from individuals with peripheral neuropathy into pluripotent stem cells is creating new hope for the development of treatments for ALS, too. 

Our Experts

University of Michigan
Sami Barmada wants to answer a very basic question about ALS: why motor neurons? Of all the different types of neurons in the body (and scientists estimate there are probably several hundred), it’s only motor neurons that are affected in ALS. Knowing why this is, Barmada believes, could be the key to developing new potential treatments that could prevent the deterioration and death of motor neurons. 
Meet Our Experts